LHCG logo

LHC Group, Inc. (LHCG) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

169.81$'dan işlem gören LHC Group, Inc. (LHCG), 5289360747 değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 45/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 8 Şub 2026
45/100 AI Puanı PD 5B Hacim 2M

LHC Group, Inc. (LHCG) Sağlık ve Boru Hattı Genel Bakışı

CEOKeith G. Myers
Çalışanlar29000
MerkezLafayette, LA, US
Halka Arz Yılı2005
SektörHealthcare

LHC Group delivers comprehensive post-acute healthcare services, capitalizing on the growing demand for in-home care and hospice solutions, driven by an aging population and a focus on cost-effective care delivery, positioning them as a key player in the expanding healthcare continuum.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 8 Şub 2026

Yatırım Tezi

LHC Group presents a notable research candidate due to its strategic focus on the expanding post-acute care market, driven by demographic trends and a shift towards value-based healthcare. With a market capitalization of $5.29 billion and a profit margin of 2.6%, LHC Group is positioned to benefit from the aging population and the increasing preference for home-based care. Key value drivers include the expansion of its service offerings, strategic acquisitions, and the growing demand for hospice and community-based services. The company's beta of 0.42 suggests lower volatility compared to the broader market. While the P/E ratio is high at 86.41, future growth catalysts, such as favorable regulatory changes and continued market penetration, could justify the valuation.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Operates 557 home health service locations, providing a broad geographic reach for in-home care.
  • Offers hospice services in 170 locations, addressing the growing need for end-of-life care.
  • Provides home and community-based services in 136 locations, supporting independent living for seniors.
  • Maintains a gross margin of 38.7%, indicating efficient cost management in service delivery.
  • Market capitalization of $5.29 billion reflects investor confidence in the company's market position and growth potential.

Rakipler & Benzerleri

Güçlü Yönler

  • Diversified service offerings across the post-acute care continuum.
  • Extensive network of locations providing broad geographic reach.
  • Strong relationships with Medicare and other payers.
  • Experienced management team with a proven track record of growth.

Zayıflıklar

  • High dependence on government reimbursement rates.
  • Exposure to regulatory changes and compliance risks.
  • Competition from other national and regional providers.
  • Relatively high P/E ratio compared to industry peers.

Katalizörler

  • Ongoing: Demographic trends driving increased demand for post-acute care services.
  • Ongoing: Shift towards value-based care creating opportunities for strategic partnerships.
  • Upcoming: Potential for regulatory changes that could benefit the home health and hospice industries.
  • Ongoing: Strategic acquisitions to expand geographic reach and service offerings.

Riskler

  • Potential: Changes in Medicare reimbursement rates could negatively impact revenue.
  • Ongoing: Increased competition from other providers could erode market share.
  • Ongoing: Rising labor costs and workforce shortages could pressure profitability.
  • Potential: Economic downturn could reduce patient demand for elective services.
  • Potential: Regulatory scrutiny and compliance requirements could increase operating costs.

Büyüme Fırsatları

  • Expansion of Home Health Services: The home health market is experiencing significant growth due to the increasing preference for in-home care among seniors. LHC Group can capitalize on this trend by expanding its geographic footprint and service offerings within its existing home health locations. The market for home healthcare is projected to reach $300 billion by 2030, presenting a substantial opportunity for LHC Group to increase its market share through strategic acquisitions and organic growth.
  • Growth in Hospice Services: The demand for hospice care is rising as the population ages and awareness of end-of-life care options increases. LHC Group can expand its hospice services by establishing new locations and partnering with healthcare providers to offer comprehensive palliative care solutions. The hospice care market is expected to grow at a rate of 7% annually over the next five years, providing a significant growth opportunity for LHC Group.
  • Development of Community-Based Services: As more seniors seek to maintain their independence at home, the demand for community-based services, such as assistance with daily living activities, is increasing. LHC Group can expand its community-based service offerings to meet this growing need and provide a continuum of care for its patients. The market for community-based services is projected to reach $100 billion by 2028, offering a substantial growth opportunity for LHC Group.
  • Strategic Acquisitions: LHC Group has a history of successful acquisitions, which have allowed it to expand its geographic footprint and service offerings. The company can continue to pursue strategic acquisitions to further strengthen its market position and capitalize on the fragmented post-acute care market. The company can target smaller regional players to expand its reach and service offerings.
  • Healthcare Innovations (HCI) Expansion: LHC Group's Healthcare Innovations segment provides strategic health management services to accountable care organizations (ACOs). As the healthcare industry continues to shift towards value-based care, the demand for these services is expected to increase. LHC Group can expand its HCI segment by partnering with more ACOs and developing new innovative solutions to improve patient outcomes and reduce healthcare costs. This segment allows LHC Group to diversify its revenue streams and capitalize on the growing trend of value-based care.

Fırsatlar

  • Expansion into new geographic markets.
  • Strategic acquisitions to increase market share.
  • Development of new innovative service offerings.
  • Partnerships with accountable care organizations.

Tehditler

  • Changes in Medicare reimbursement policies.
  • Increased competition from other providers.
  • Rising labor costs and workforce shortages.
  • Economic downturn impacting patient demand.

Rekabet Avantajları

  • Established network of home health, hospice, and community-based service locations.
  • Strong relationships with healthcare providers and payers.
  • Expertise in navigating the complex regulatory environment of the post-acute care industry.
  • Reputation for providing high-quality care and achieving positive patient outcomes.

LHCG Hakkında

Founded in 1994 and headquartered in Lafayette, Louisiana, LHC Group, Inc. has evolved into a leading provider of post-acute care services. The company focuses primarily on Medicare beneficiaries, offering a range of services designed to meet the needs of patients recovering from illness or injury. LHC Group operates through five distinct segments: Home Health Services, which provides skilled nursing and therapy; Hospice Services, offering palliative care and emotional support; Home and Community-Based Services, assisting with daily living activities; Facility-Based Services, treating patients with severe conditions requiring intensive care; and Healthcare Innovations (HCI), delivering strategic health management to accountable care organizations. LHC Group's extensive network includes 557 home health locations, 170 hospice locations, 136 community-based service locations, and 12 long-term acute care hospitals as of December 31, 2021. The company's commitment to quality care and strategic expansion has solidified its position in the fragmented post-acute care market, allowing it to capitalize on the increasing demand for in-home healthcare solutions.

Ne Yaparlar

  • Provides skilled nursing services in patients' homes.
  • Offers physical, occupational, and speech therapy.
  • Delivers hospice care for patients with terminal illnesses.
  • Assists with daily living activities through community-based services.
  • Operates long-term acute care hospitals for patients with severe medical conditions.
  • Provides strategic health management services to accountable care organizations.

İş Modeli

  • Generates revenue through providing home health services reimbursed by Medicare, Medicaid, and private insurance.
  • Earns revenue from hospice services, including palliative care and symptom management.
  • Receives payments for community-based services, such as assistance with grooming and meal preparation.
  • Operates facility-based services, including long-term acute care hospitals, generating revenue from patient care.

Sektör Bağlamı

LHC Group operates within the growing post-acute care industry, which is driven by an aging population and increasing demand for cost-effective healthcare solutions. The market is characterized by a shift towards home-based care, as patients and payers seek alternatives to traditional institutional settings. LHC Group competes with other national and regional providers of home health, hospice, and community-based services. The industry is subject to regulatory changes and reimbursement pressures, requiring companies to adapt and innovate to maintain profitability. LHC Group's diversified service offerings and strategic acquisitions position it favorably within this competitive landscape.

Kilit Müşteriler

  • Medicare beneficiaries requiring post-acute care.
  • Patients with terminal illnesses needing hospice services.
  • Seniors seeking assistance with daily living activities.
  • Accountable care organizations seeking strategic health management services.
AI Güveni: 72% Güncellendi: 8 Şub 2026

Finansallar

Grafik & Bilgi

LHC Group, Inc. (LHCG) hisse senedi fiyatı: $169.81 (+0.00, +0.00%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

LHCG için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

LHCG için Wall Street fiyat hedefi analizi.

MoonshotScore

45/100

Bu puan ne anlama geliyor?

MoonshotScore, LHCG'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

LHCG Healthcare Hisse Senedi SSS

LHCG için değerlendirilmesi gereken temel faktörler nelerdir?

LHC Group, Inc. (LHCG) şu anda yapay zeka skoru 45/100, düşük puanı gösteriyor. Temel güçlü yan: Diversified service offerings across the post-acute care continuum.. İzlenmesi gereken birincil risk: Potential: Changes in Medicare reimbursement rates could negatively impact revenue.. Bu bir finansal tavsiye değildir.

LHCG MoonshotScore'u nedir?

LHCG şu anda MoonshotScore'da 45/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

LHCG verileri ne sıklıkla güncellenir?

LHCG fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler LHCG hakkında ne diyor?

LHCG için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

LHCG'a yatırım yapmanın riskleri nelerdir?

LHCG için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Changes in Medicare reimbursement rates could negatively impact revenue.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

LHCG'ın P/E oranı nedir?

LHCG için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için LHCG'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

LHCG aşırı değerli mi, yoksa düşük değerli mi?

LHC Group, Inc. (LHCG)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

LHCG'ın temettü verimi nedir?

LHC Group, Inc. (LHCG) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Stock data pending update. Financial data based on the most recent available information.
Veri Kaynakları

Popüler Hisseler